Home » GC News & Media » Media Coverage » Media Archives
Media Archives
POZ Magazine features "Rebel Gel"
" A sleek strawberry-flavored microbicide in a lipstick case would be the must-have purse item of the coming decade." The June cover story of POZ, a magazine founded primarily to get information to HIV positive persons to improve the quality of their lives, features microbicides as the new up and coming hip technology that can save thousands and thousands of people from infection.
Microbicides has come a long way; as POZ points outs the "unfortunate name sounds like a fungus-eradication product" and doesn’t get too far in getting people’s attention. But now, as more and more people are looking beyond the name, microbicides have become a "must have." Read about the three promising products that are in clinical trials and the funding and advocacy needed to push them forward.
Download 
the article in PDF format! (Large file: 1.75 MB)
Baltimore City Paper
The front page of the Baltimore City Paper, March 6-12th 2002 issue headlines, "Microbe Managers" and pictures Drs. Thomas Moench, Kristen Khanna and Richard Cone, directors of ReProtect LLC and scientists behind BufferGel. The article describes the need for microbicides while detailing the challenges of developing them. The Baltimore paper reaches thousands of people in Maryland -- perhaps microbicides will soon become a household word.
Read the Full Article
Download the PDF: 11 pages, 90KB.
Making Whoopee Over Gel Condom
The Ottawa Citizen published an article on Saturday, April 6, 2002 on A birth-control gel that also protects against HIV and other venereal diseases is getting a yawn from industry. But a passionate grassroots movement is taking up the cause.
Read the Full Article
Letters to the Editor
The Global Campaign writes to the editor of The New Yorker to discuss the December 17, 2001 article called India's Plague.
Michael Specter astutely sees "the plight of women" as the most discouraging obstacle to fighting the AIDS epidemic in India (India's Plague, December 17). What's even more discouraging is the lack of will anywhere to produce a new prevention option for women. That's why women are mobilizing worldwide to put pressure on their governments and the pharmaceutical industry to act now to save women's lives.